Uzbekistan Stocks — Valuations, P/E & Dividends

This season's standout divergence is not between sectors but within them: two consumer-facing names, Trust and Universal, delivered revenue acceleration while Hamkor, despite a still-impressive 19.2% top-line gain, saw its growth rate nearly halve from 38.4% a year ago. The real story is the market's willingness to pay up for momentum—Trust trades at 14.1x earnings despite slower net-profit growth than Hamkor's 4.9x multiple.

Revenue growth, biggest movers (YoY)

Trust and Universal accelerate while Hamkor decelerates sharply

Trust was the quarter's top performer, with revenue surging 32.2% year over year—a sharp acceleration from 20.8% in the prior period. Net profit growth, however, lagged at 15.9%, suggesting margin pressure from investment or competition. Universal also impressed, lifting revenue 30.9% (virtually matching last year's 30.5% pace) but net profit growth collapsed to just 6.6% from 64.2%—a stark margin squeeze that investors seem willing to overlook given the 4.4x P/E. Hamkor, meanwhile, slowed from 38.4% revenue growth to 19.2%, though net profit held steady at +18.9% versus +18.3%—a sign of cost discipline that the market is not rewarding.

UZEX proves a steady compounder in an uneven field

While consumer names grab headlines, UZEX quietly delivered the most balanced result: revenue grew 11.8% (slightly below last year's 13.5%), but EBITDA accelerated to +18.3% and net profit jumped 20.5%—the strongest profit expansion in the group. With a 3-year revenue CAGR of 4.2%, UZEX is the only name offering a multi-year track record, and its 8.5x P/E sits between the extremes. This is not a flashy story, but it is a reliable one.

The plot twist: Trust's rich multiple defies profit deceleration

The biggest surprise is Trust's valuation. Despite net profit growth of 15.9%—slower than Hamkor's 18.9% and far below its own prior-period net profit decline of -0.4%—Trust commands a P/E of 14.1x, more than double Hamkor's 4.9x. Investors are clearly pricing in future acceleration, but with revenue growth already decelerating from 32.2%? Wait—Trust's revenue actually accelerated from 20.8% to 32.2%, so the market is betting on sustained top-line momentum. The risk is that margin compression continues, making the 14.1x multiple look stretched.

Value hunters eye Hamkor and Universal as deep-value plays

For value-focused investors, the contrast is stark. Hamkor, growing revenue 19.2% and net profit 18.9%, trades at just 4.9x earnings—a multiple that implies the market sees its deceleration as structural. Universal, with 30.9% revenue growth but razor-thin profit growth, fetches 4.4x, pricing in further margin erosion. UZEX at 8.5x looks fair for its steady but slower growth. Trust at 14.1x is the only name that appears expensive relative to its profit delivery.

No dividend data was provided for any of the four names, so income investors will need to look elsewhere this season. The focus remains squarely on growth and valuation.

The long view: UZEX's CAGR stands alone, but watch Trust's margin trajectory

Only UZEX provides a multi-year revenue CAGR—4.2%—giving it a rare compound-growth narrative in this group. For the others, this season's numbers are the only guide. Looking ahead, the key tension to watch is whether Trust can sustain its revenue acceleration while expanding margins, or if Universal's margin squeeze deepens further. Hamkor's ability to stabilize growth near 20% while maintaining profit discipline makes it the most intriguing value bet. The next quarter will reveal whether the market's current pricing—rewarding momentum and punishing deceleration—is justified.

Players: growth & yield (no absolute levels)